New needle biopsy could spare women unnecessary uterus surgery
NCT ID NCT07264660
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new, less invasive biopsy method for uterine masses. The procedure uses a thin needle guided by ultrasound through the cervix to take a tissue sample. Researchers want to see if it can accurately tell benign from malignant growths, potentially helping women avoid unnecessary surgery. The study will enroll 42 women who are already scheduled for surgical removal of a uterine mass.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transcervical True-Cut Biopsy (procedure)
- What this could lead to
- If successful, this biopsy method could provide a reliable, less invasive way to diagnose uterine masses, helping many women avoid unnecessary surgery.
- What could go wrong
- This is a small, early-stage study with only 42 participants. The technique may not be accurate enough to replace current methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 42 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
• Women diagnosed with uterine tumor-like masses by imaging and scheduled for surgical excision
- Ages
-
Children (under 18), adults (18 to 64) and older adults (65 and over)
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * • Women diagnosed with uterine tumor-like masses by imaging and scheduled for surgical excision. * Non-virgin patients . Exclusion Criteria: * • Patients with active genital tract infection. * Patients with bleeding disorders or on uncorrected anticoagulation therapy. * .Pregnancy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Uterine tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.